Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Philadelphia-negative myeloproliferative neoplasms (MPN) are clonal bone marrow disorders originating from a single mutated hematopoietic stem cell.
• Key mutations in JAK2, CALR, and MPL genes result in constitutive activation of JAK-STAT signaling pathways.
• Clinical manifestations include myeloproliferation, splenomegaly, and constitutional symptoms.

Purpose of the Study:

• To review the roles of various cellular components and soluble mediators in the pathogenesis of myelofibrosis (MF) within MPN.
• To highlight recent advancements in therapeutic strategies for MPN and MF.

Main Methods:

• Literature review focusing on cellular components (monocytes, megakaryocytes, mesenchymal stromal cells) and cytokines in MPN.
• Analysis of recent therapeutic advances targeting MPN and MF.

Main Results:

• Malignant and non-malignant bone marrow cellular components significantly contribute to MPN pathogenesis and MF development.
• Cytokines and soluble mediators play crucial roles in the progression of myelofibrosis.
• Recent therapeutic strategies show promise in managing MPN and its complications.

Conclusions:

• Understanding the interplay of diverse bone marrow constituents is vital for comprehending MPN and MF.
• Targeting both malignant and non-malignant cells, along with specific cytokines, offers a promising avenue for novel MF therapies.